[HTML][HTML] Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration
Y Sun, D Sun, X Zhang, Y Zhang, Y Lin - Frontiers in Endocrinology, 2022 - frontiersin.org
Radioiodine (131I) therapy (RAI) has been utilized for treating differentiated thyroid cancer
(DTC) for decades, and its uses can be characterized as remnant ablation, adjuvant therapy …
(DTC) for decades, and its uses can be characterized as remnant ablation, adjuvant therapy …
Radioactive iodine therapy decreases the recurrence of intermediate-risk PTC with low thyroglobulin levels
T Tian, Z Qi, S Huang, H Wang… - The Journal of Clinical …, 2023 - academic.oup.com
Context Whether radioactive iodine therapy (RAIT) is necessary for intermediate-risk
papillary thyroid cancer (PTC) after total thyroidectomy is still lacking reliable evidence …
papillary thyroid cancer (PTC) after total thyroidectomy is still lacking reliable evidence …
[HTML][HTML] Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect
X Li, H Zheng, C Ma, Y Ji, X Wang, D Sun… - Frontiers in …, 2024 - frontiersin.org
Objective This retrospective study aims to evaluate the therapeutic effect of varying dosages
of adjuvant radioactive iodine (RAI) therapy on intermediate-risk papillary thyroid carcinoma …
of adjuvant radioactive iodine (RAI) therapy on intermediate-risk papillary thyroid carcinoma …
Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer
H Hei, Z Luo, C Zheng, W Gong, B Zhou, J Fang, J Qin - Oral Oncology, 2023 - Elsevier
Objectives To investigate the impact of the lymph node ratio (LNR) on postoperative
thyroglobulin (Tg) levels in patients with papillary thyroid carcinoma (PTC). Patients and …
thyroglobulin (Tg) levels in patients with papillary thyroid carcinoma (PTC). Patients and …
Nuclear Imaging and Therapy of Thyroid Disorders
S Muzahir, EE Grady - Exon Publications, 2023 - exonpublications.com
This chapter reviews the basics of molecular imaging in thyroid disease and special
considerations in radioiodine therapy of benign diseases such as Graves' disease …
considerations in radioiodine therapy of benign diseases such as Graves' disease …
[HTML][HTML] Delayed initial radioiodine adjuvant therapy does affect biochemical response in intermediate-to high-risk differentiated thyroid cancer
F Yu, X Li, Y Ji, J Tan, G Zhang, P Wang… - Frontiers in …, 2021 - frontiersin.org
Background There are no definite recommendations on the optimal time of initiating
radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC) patients in current …
radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC) patients in current …
[HTML][HTML] Differential distribution and prognostic value of CD4+ T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied …
ZY Shi, SX Zhang, CH Li, D Fan, Y Xue… - Frontiers in …, 2022 - frontiersin.org
Differentiated thyroid cancer is the most frequently diagnosed endocrine tumor. While
differentiated thyroid cancers often respond to initial treatment, little is known about the …
differentiated thyroid cancers often respond to initial treatment, little is known about the …
Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without …
R Sa, T Yang, Z Zhang, F Guan - The Oncologist, 2024 - academic.oup.com
Background We aimed to develop a machine-learning model for predicting treatment
response to radioiodine (131I) therapy and thyrotropin (TSH) suppression therapy in …
response to radioiodine (131I) therapy and thyrotropin (TSH) suppression therapy in …
Outcome of patients with differentiated thyroid cancer treated with empirical radioiodine therapy on the basis of Thyroglobulin Elevation Negative Iodine Scintigraphy …
L Yuan, J Wang, L Pan, H Feng, P Chen, J Luo… - Annals of Nuclear …, 2023 - Springer
Background For differentiated thyroid cancer (DTC) patients with thyroglobulin (Tg) elevation
and negative iodine scintigraphy (commonly termed" TENIS" syndrome) after thyroidectomy …
and negative iodine scintigraphy (commonly termed" TENIS" syndrome) after thyroidectomy …
Development of a predictive nomogram for intermediate-risk differentiated thyroid cancer patients after fixed 3.7 GBq (100mCi) radioiodine remnant ablation
L Lu, Q Li, Z Ge, Y Lu, C Lin, J Lv, J Huang… - Frontiers in …, 2024 - frontiersin.org
Objectives The objective of this study was to develop a predictive nomogram for
intermediate-risk differentiated thyroid cancer (DTC) patients after fixed 3.7 GBq (100mCi) …
intermediate-risk differentiated thyroid cancer (DTC) patients after fixed 3.7 GBq (100mCi) …